XOMA Royalty (XOMA) Other Operating Expenses (2011 - 2026)
XOMA Royalty (XOMA) reported Other Operating Expenses of $27000.0 for Q1 2026, up 100.42% on a YoY basis from $13472.0 in Q1 2025, and up 100.27% sequentially from -$10.1 million in Q4 2025.
XOMA Royalty (XOMA) Other Operating Expenses (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 14 years of Other Operating Expenses data on file, last reported at $27000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses rose 100.42% year-over-year to $27000.0; the trailing twelve-month figure through Mar 2026 stood at -$15.4 million (down 1878.59% YoY), and the FY2025 full-year result was -$26.5 million, down 6219.09% from the prior year.
- Other Operating Expenses climbed to $27000.0 in Q1 2026, from -$10.1 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $7.0 million in Q3 2024 to a low of -$10.1 million in Q4 2025.
- A 5-year average of -$1.8 million and a median of $27000.0 in 2026 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses plunged 3236.89% in 2024 and jumped 100.42% in 2026, its largest moves.
- Tracing XOMA's Other Operating Expenses over 5 years: stood at $97000.0 in 2022, then jumped by 1754.64% to $1.8 million in 2023, then dropped by 9.95% to $1.6 million in 2024, then sank by 721.36% to -$10.1 million in 2025, then soared by 100.27% to $27000.0 in 2026.
- Business Quant data shows XOMA's Other Operating Expenses at $27000.0 in Q1 2026, -$10.1 million in Q4 2025, and -$5.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | -10.07 Mn |
| Jun 30, 2025 | -5.33 Mn |
| Mar 31, 2025 | -6.50 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 7.01 Mn |
| Jun 30, 2024 | -1.26 Mn |
| Mar 31, 2024 | -7.06 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 225,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2018 | -543,000.00 |
| Dec 31, 2017 | -1,000.00 |
| Jun 30, 2017 | -1.46 Mn |
| Mar 31, 2017 | -2.02 Mn |
| Dec 31, 2016 | -4.55 Mn |
| Jun 30, 2016 | 21,000.00 |
| Mar 31, 2016 | -36,000.00 |
| Dec 31, 2015 | -1.14 Mn |